Alembic Pharmaceuticals has received U.S. Food and Drug Administration final approval for its abbreviated new drug application for Carbidopa, Levodopa and Entacapone Tablets in different strengths.

Alembic Pharmaceuticals Ltd on Monday said it has received tentative approval from the US health regulator for its Bosutinib tablets used in the treatment of certain types of cancer. The tentative ...

Send a note to Doug Wintemute, Kara Coleman Fields and our other editors. We read every email. By submitting this form, you agree to allow us to collect, store, and potentially publish your provided ...

Led by Prysm Capital and Accenture with participation from Silver Lake Waterman, Liquid 2 Ventures, NextEquity, Friends & Family Capital, and WndrCo, this round positions Alembic among the top AI labs ...

Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...

Alembic Technologies has raised $145 million in Series B and growth funding at a valuation 15 times higher than its previous round, betting that the next competitive advantage in artificial ...

Alembic Pharmaceuticals shares rose 2.3 per cent on Tuesday, August 19, 2025, logging an intra-day high at ₹996.15 per share on BSE. At 11:29 AM, Alembic Pharmaceuticals share price was trading 1.88 ...

Pivya has been proven safe in three studies. Credit: Summit Art Creations/Shutterstock. Alembic Pharmaceuticals has acquired UTILITY therapeutics, expanding its portfolio with the addition of Pivya ...

Alembic Pharmaceuticals has acquired Utility Therapeutics Ltd for $12 million. The acquisition aims to strengthen Alembic's presence in the US market. Alembic will commercialise Utility's FDA-approved ...

Alembic Pharmaceuticals share price: Pharmaceuticals company Alembic Pharmaceuticals shares were trading higher on Thursday, July 3, 2025, with the scrip rising up to 2.05 per cent to hit an intraday ...

Alembic Pharmaceuticals Inc., a wholly owned subsidiary of Alembic Pharmaceuticals Ltd., has acquired Utility Therapeutics Ltd. to expand its UTI drug portfolio in the US. The acquisition includes 100 ...

Shares of Alembic Pharmaceuticals soared more than 12 percent in intra-day trade on Monday, June 30, after the company announced that it had secured final approval from the US Food and Drug ...